SubsidieMeestersUnveiling the Molecular Secrets of Reproductive Mood Disorders: a Multi-Omics Approach Project
The MoodMAP project aims to identify molecular markers and biological factors of reproductive mood disorders to improve diagnosis, prevention, and treatment strategies for women's mental health.
Projectdetails
Introduction
Reproductive mood disorders (RMDs), including premenstrual disorder and postpartum depression, have a significant impact on women and their families, contributing to the well-known gender gap in mental health. However, effectively diagnosing and treating RMDs remains an ongoing challenge.
Hormonal Influence
These conditions are closely tied to hormonal changes during menstruation and childbirth, indicating a shared vulnerability. While the precise mechanisms are not yet fully understood, emerging data, including my work, supports the hypothesis that genetic predisposition, chronic inflammation, and metabolic dysfunction play pivotal roles in the development of RMDs.
Project Goals
The MoodMAP project aims to:
- Discover novel molecular markers for RMDs.
- Provide insights into the biological factors influencing varying vulnerabilities to mood disorders in women.
- Enhance diagnostic, preventative, and treatment strategies for RMDs.
Methodology
The endeavor leverages three Nordic population-based cohorts: a) To DEPICT a comprehensive architecture of RMDs by integrating genomic, inflammatory proteomic, and metabolomic data. b) To TRIANGULATE evidence for identifying biologically functional and causal biomarkers using cell data manipulated with hormones and advanced epidemiologic methods. c) To PREDICT treatment outcomes, including treatment resistance and subsequent suicidal behavior, through multi-omics data and machine-learning methods.
Innovative Approach
MoodMAP adopts an innovative approach by studying both RMDs together, aiming to uncover the biological basis of female vulnerability to mood disorders through multi-omics data.
Potential Impact
By integrating advanced omics techniques, hormone-manipulated cell data, and cutting-edge epidemiologic and statistical methods, MoodMAP holds the potential to:
- Understand the psychiatric sensitivity associated with sex hormones.
- Drive transformative changes in diagnosis, prevention, and treatment strategies for RMDs.
- Ultimately contribute to the reduction of the gender gap in mental health.
Financiële details & Tijdlijn
Financiële details
| Subsidiebedrag | € 1.499.999 |
| Totale projectbegroting | € 1.499.999 |
Tijdlijn
| Startdatum | 1-1-2025 |
| Einddatum | 31-12-2029 |
| Subsidiejaar | 2025 |
Partners & Locaties
Projectpartners
- KAROLINSKA INSTITUTETpenvoerder
Land(en)
Vergelijkbare projecten binnen European Research Council
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
Deciphering female’s SEx hormones - MIcrobiota interactions during a menstrual CYCLE for an efficient personalized medicine in cardiometabolic disordersThe SEMICYCLE project aims to identify female-specific microbiota features influencing glycaemic and lipid metabolism to improve prevention and treatment strategies for cardiometabolic disorders in women. | ERC Starting... | € 1.499.286 | 2023 | Details |
Menstrual blood multiomics analysis to better diagnose, understand and treat endometriosisThe MensEndoDiag project seeks to identify diagnostic and prognostic biomarkers for endometriosis using menstrual fluid, while exploring new therapeutic approaches to improve patient outcomes. | ERC Starting... | € 1.479.399 | 2023 | Details |
Hormone-microbiome interactions as a key-player in female healthThis project aims to investigate hormone-microbiome interactions in women to understand their impact on health and infertility, ultimately identifying biomarkers and new therapeutic strategies. | ERC Starting... | € 1.499.485 | 2022 | Details |
Modelling and maintaining maternal mental healthThe HealthyMom project aims to investigate the impact of pregnancy loss on maternal brain plasticity and mental health through multimodal brain imaging and genetic analysis, enhancing understanding of women's health. | ERC Consolid... | € 1.998.569 | 2024 | Details |
Multi-omics characterization of immune triggers in Moyamoya diseaseThe project investigates the link between immune responses to infections and the onset of Moyamoya disease in RNF213 mutation carriers using a multi-omics approach to uncover underlying mechanisms. | ERC Consolid... | € 1.981.593 | 2023 | Details |
Deciphering female’s SEx hormones - MIcrobiota interactions during a menstrual CYCLE for an efficient personalized medicine in cardiometabolic disorders
The SEMICYCLE project aims to identify female-specific microbiota features influencing glycaemic and lipid metabolism to improve prevention and treatment strategies for cardiometabolic disorders in women.
Menstrual blood multiomics analysis to better diagnose, understand and treat endometriosis
The MensEndoDiag project seeks to identify diagnostic and prognostic biomarkers for endometriosis using menstrual fluid, while exploring new therapeutic approaches to improve patient outcomes.
Hormone-microbiome interactions as a key-player in female health
This project aims to investigate hormone-microbiome interactions in women to understand their impact on health and infertility, ultimately identifying biomarkers and new therapeutic strategies.
Modelling and maintaining maternal mental health
The HealthyMom project aims to investigate the impact of pregnancy loss on maternal brain plasticity and mental health through multimodal brain imaging and genetic analysis, enhancing understanding of women's health.
Multi-omics characterization of immune triggers in Moyamoya disease
The project investigates the link between immune responses to infections and the onset of Moyamoya disease in RNF213 mutation carriers using a multi-omics approach to uncover underlying mechanisms.
Vergelijkbare projecten uit andere regelingen
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
A Multi-Omics Approach for Novel Drug Targets, Biomarkers and Risk Algorithms for Myocardial InfarctionTargetMI aims to rapidly discover novel drug targets and biomarkers for myocardial infarction using a high-throughput multi-omic approach on 1000 samples, enhancing clinical risk prediction and translation. | EIC Pathfinder | € 3.999.840 | 2023 | Details |
DiaPro-MSHet project ontwikkelt de DiaPro MS-app om op basis van een geïntegreerd moleculair landschap betere diagnostiek en prognose voor MS-patiënten mogelijk te maken. | Mkb-innovati... | € 155.531 | 2015 | Details |
Mapping the mycobiomeDit project ontwikkelt en valideert een innovatieve detectiemethode voor het mycobiome in de darm, met als doel de rol ervan in gezondheid en ziekte te begrijpen en therapeutische strategieën te verbeteren. | Mkb-innovati... | € 155.400 | 2015 | Details |
A Multi-Omics Approach for Novel Drug Targets, Biomarkers and Risk Algorithms for Myocardial Infarction
TargetMI aims to rapidly discover novel drug targets and biomarkers for myocardial infarction using a high-throughput multi-omic approach on 1000 samples, enhancing clinical risk prediction and translation.
DiaPro-MS
Het project ontwikkelt de DiaPro MS-app om op basis van een geïntegreerd moleculair landschap betere diagnostiek en prognose voor MS-patiënten mogelijk te maken.
Mapping the mycobiome
Dit project ontwikkelt en valideert een innovatieve detectiemethode voor het mycobiome in de darm, met als doel de rol ervan in gezondheid en ziekte te begrijpen en therapeutische strategieën te verbeteren.